Expression of PKD1 and PKD3 genes in heart tissue during early embryonic development in mice

doi:10.12092/j.issn.1009-2501.2018.08.004

Abstract

CLC Number:

R965.2

ING Ran,XIE Qiying,LI Fei,DENG Guiyuan,LONG Tianyi,ZOU Juanlin,OUYANG Kunfu. Expression of PKD1 and PKD3 genes in heart tissue during early embryonic development in mice[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 862-866.

References

［1］Graham E, Bergmann O. Dating the heart: exploring cardiomyocyte renewal in humans［J］.Physiology (Bethesda), 2017, 32(1):33-41.
［2］Mozaffarian D,Benjamin EJ,Go AS,et al. Executive summary: heart disease and stroke statistics2016 update: a report from the American Heart Association［J］. Circulation, 2016,133(4), 447-454.
［3］Rozengurt E. Protein kinase D signaling: multiple biological functions in health and disease［J］.Physiology (Bethesda), 2011, 26(1):23-33.
［4］Zhang L, Li J, Zhang P, et al. PI4KIIα regulates insulin secretion and glucose homeostasis via a PKDdependent pathway［J］. Biophys Rep, 2018, 4(1):25-38.
［5］Fielitz J, Kim MS, Shelton JM, et al. Requirement of protein kinase D1 for pathological cardiac remodeling［J］.Proc Natl Acad Sci U S A,2008 ,105(8):3059-3063.
［6］Matthews SA, Navarro MN, Sinclair LV, et al. Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells［J］.Biochem J, 2010, 432(1):153-163.
［7］Bergmann O, Zdunek S, Felker A, et al. Dynamics of cell generation and turnover in the human heart［J］.Cell, 2015, 161(7):1566-1575.
［8］周桑,丁雪燕,秦永文.心脏再生分子机制的研究进展［J］.重庆医学, 2017, 46(2):256-258.
［9］Brando KO, Tabel VA, Atsma DE, et al. Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies［J］.Dis Model Mech, 2017,10(9):1039-1059.
［10］Scott IC. Life before Nkx2.5: cardiovascular progenitor cells: embryonic origins and development［J］.Curr Top Dev Biol, 2012, 100:1-31.
［11］Campione M, Franco D.Current perspectives in cardiac laterality［J］.J Cardiovasc Dev Dis, 2016, 3(4): 34.
［12］Nimura K, Kaneda Y.Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing［J］.J Hum Genet,2016,61(1):5-12.
［13］吕子强,吕紫阳,马成华,等.组蛋白去乙酰化酶抑制剂联合用药研究进展［J］.中国临床药理学与治疗学,2016 , 21 (5) :579-585.
［14］Kim Y, Phan D, van Rooij E, et al. The MEF2D transcription factor mediates stressdependent cardiac remodeling in mice［J］.J Clin Invest, 2008, 118(1):124-132.
［15］Dirkx E, van Eys GJ, Schwenk RW, et al. Protein kinaseD1 overexpression prevents lipidinduced cardiac insulin resistance［J］.J Mol Cell Cardiol, 2014, 76:208-217.
［16］Sin YY, Martin TP, Wills L, et al. Small heat shock protein 20 (Hsp20) facilitates nuclear import of protein kinase D 1 (PKD1) during cardiac hypertrophy［J］.Cell Commun Signal, 2015, 13:16.
［17］Li C, Li J, Cai X, et al. Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors［J］.J Biol Chem, 2011, 286(47):40782-40791.

[1]	CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208.
[2]	WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali. Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218.
[3]	ZHU Ruifang, GUO Dongkai, ZHI Hui, JIANG Yiguo, ZHANG Yueling, QIAN Xiaoping, JI Shiliang. Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1219-1226.
[4]	LI Fei, DING Huiqin, CHEN Mengjing. Isonlosinine induces autophagy of PC9 cells by ERK signaling pathway in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1235-1240.
[5]	SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju. Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262.
[6]	CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
[7]	WANG Xiu, JI Qilin, PEI Wenjun, ZENG Ying. 3-bromopyruvate cholesterol ester enhances the sensitivity of breast cancer cells to tamoxifen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1093-1100.
[8]	HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning. Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108.
[9]	LIAO Mengling, WANG Yan, LUO Jing, WANG Nuoyan, HUA Ling, ZHANG Yu, DENG Fei, YUAN Yue, ZHOU Jun, ZHOU Hong. Molecular mechanism of artesunate attenuates the release of proinflammatory cytokines from macrophages [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 969-978.
[10]	YOU Rongli, HUANG Yurong, MAORui, HAI Lina, WANG Yingli, WANG Yan. Mechanism of compound kushen injection in the treatment of lung cancer based on serum metabolomics and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 988-999.
[11]	WANG Ruyue, XIE Fei, WANG Xin, LI Hongyu. Therapeutic effect of lienal polypeptide injection on bone marrow suppression and immunodeficiency in KM mice following chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1000-1007.
[12]	MAO Jun, RONG Yu, LI Yangen, XIONG Dengxi, ZHAO Peng, ZHA Zhengjiang. Effect and safety of flurbiprofen axetil in the analgesic treatment of patients with craniocerebral injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1056-1060.
[13]	MA Xiankang, YANG Lixia, CUI Yangyang, MI Denghai. Angelica polysaccharides improve hepatic endoplasmic reticulum stress by inhibiting the expression of GRP78, p-PERK and p-Eif2α in diabetic KK-Ay mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 926-936.
[14]	WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng. Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727.
[15]	LI Shixu, LI Linyun, WANG Xin, LI Ke, BIAN Hua. Effects of Ginkgo biloba extract on renal injury in rats with experimental renal failure through miR-145/FOXO1 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 728-735.